Short Wave That Revolutionary Gene-Editing Experiment? So Far So Good.
Nov 20, 2019
Join NPR health correspondent Rob Stein as he shares the incredible journey of Victoria Gray, the first patient to undergo a revolutionary CRISPR gene-editing treatment for sickle cell disease. Rob discusses the impressive early results, showcasing the production of healthy red blood cells and the emotional weight of a mother's anxieties about the treatment. This inspiring narrative highlights the transformative potential of gene editing, while also addressing the importance of long-term safety and efficacy monitoring.
AI Snips
Chapters
Transcript
Episode notes
Victoria Gray's Story
- Victoria Gray, a 34-year-old mother of four from Mississippi, has sickle cell disease.
- This genetic condition causes misshapen red blood cells, leading to severe pain and a shortened lifespan.
CRISPR Treatment for Sickle Cell
- Scientists used CRISPR gene editing on Victoria Gray's bone marrow cells.
- They rewrote a gene and infused the modified cells back into her body, hoping to create healthy red blood cells.
Sickle Cell Pain
- Sickle cell disease is a cruel genetic disorder deforming red blood cells, which causes excruciating pain.
- Victoria Gray describes sudden pain attacks so severe that she'd go from laughing to needing to be carried to the ER.